Title | Description | Host | Host Type | Outcomes |
---|---|---|---|---|
AMU | TRIAL 2: A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 2 was challenged with 10^9 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups | Chicken | Broilers | 1 |
Treatment | TRIAL 1: A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 1 was challenged with 10^7 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups | Chicken | Broilers | 1 |
Treatment | TRIAL 1: A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 1 was challenged with 10^7 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups. | Chicken | Broilers | 1 |
Treatment | TRIAL 1:A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 1 was challenged with 10^7 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups | Chicken | Broilers | 1 |
Treatment | TRIAL 2: A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 2 was challenged with 10^9 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups | Chicken | Broilers | 1 |
Treatment | TRIAL 2: A novobicin- and nalidixic acid-resistant strain of Salmonella Typhimurium were used as inoclua for challenging broilers. Trial 2 was challenged with 10^9 CFU of Salmonella Typhimurium per ml. Each Trial was divided in 4 treatment groups | Chicken | Broilers | 1 |